Moderna plans 400% increase in price of Covid vaccine
Public Citizen Access to Medicines Director Peter Maybarduk and Northwestern healthcare economist Craig Garthwaite joins CNBC’s Brian Sullivan and ‘Last Call’ to discuss the debate over Moderna’s decision to raise the price of its Covid vaccine.
UP NEXT
NOW PLAYING: other
Moderna plans 400% increase in price of Covid vaccine
CNBC
UP NEXT
-
Regional elections deal blow to governing socialists in Spain
CNBC
-
Euphoric messaging around the Spanish economy was a 'big mistake' in the regional elections, expert says
-
Debt ceiling deal unlikely to spark major relief rally, investment chief says
-
Earnings expectations have to be revised upward as global economy bottoms, asset manager says
-
Spain: People's Party regional election win is a 'severe defeat' for Sanchez, says social scientist
-
China will have to deploy more fiscal stimulus and targeted easing, HSBC strategist says
-
U.S. debt ceiling deal is a 'classic compromise,' says PwC National Tax Office
-
What's next for Turkish politics?
-
Erdogan secures Turkish election win
-
China should not introduce a large stimulus package now, economist says
-
We're still optimistic about China for the medium to long term, says Deutsche Bank
-
Nvidia 'ratified' the excitement about A.I. with 'blowout earnings,' says Wharton professor Jeremy Siegel
-
A 'Big Short' investor sees financial disaster brewing in housing markets — again
-
China's economy will have a 'reasonable rebound' this year, says investment management firm
-
We have a pessimistic outlook on the Turkish lira, strategist says
-
U.S. debt ceiling deal is a 'democratic victory,' says David Roche
